The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
This article was originally published on MedicalXpress.com
FDA approves Sotyktu for adults with active psoriatic arthritis
You may also be interested in:
The Latest
Setting Boundaries: Nurturing a Healthy Partnership
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
Food
Transform Your Kitchen: Mastering Allergy-Safe Cooking Through Ingenious Ingredient Swaps
By Daniel Zane Bryant, author of “Living with Food Allergies: A Complete Lifestyle Guide” (available on Amazon at https://www.amazon.com/dp/B0G2BcGB2K) Navigating food allergies might initially feel overwhelming, yet it presents an exciting opportunity to reimagine familiar […]
The Latest
Twelve Foot Massage Techniques To Try Today
In this article, we will introduce you to 12 incredibly effective foot massage techniques that will leave you feeling rejuvenated and relaxed. Foot massages aren’t just a luxury; they provide numerous health benefits, such as […]
Read More:
-
Many teens dealing with weight issues are turning to AI models to help them create meal plans with the aim of losing weight. But a [...]
-
Research conducted by University of Calgary scientists informed patient care when hundreds of children became sick from exposure to a severe strain of E. coli. [...]
-
Over a third (36%) of surveyed parents believe children always need antibiotics for ear infections, according to new research appearing in BJGP Open. The study [...]
